Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) shares traded down 6.3% on Tuesday . The stock traded as low as $0.17 and last traded at $0.17. 719,255 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 784,450 shares. The stock had previously closed at $0.18. Azitra Stock Performance […]
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that management will present at the 2024 BIO.
ATR-04 is in development for epidermal growth factor receptor inhibitor -induced dermal toxicity, which affects approximately 150,000 patients in the US
Reduces methicillin-resistant S. aureus by.
Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.